System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Iris Zalaudek is an expert in Dermatology at Ospedale Maggiore (Italy). As of October 2026, ScienceLeadR ranks Iris Zalaudek in the top 1% of experts worldwide for Non-Melanoma Skin Neoplasms, Keratosis and Skin Neoplasms. Iris Zalaudek has authored 788 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 2 of them ongoing. SLR score: 2,483 (community average: 125). How the SLR is computed.

LeadR Profile

Iris Zalaudek Ospedale Maggiore Italy
2 483 ScienceLeadR Reputation 2483

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Oncology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2002 - 2026
Source: PubMed

University of Trieste

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 788

Citations

Citations: 27 055 1st author: 95 Last author: 204 Unique author: 8

Main journals

J Eur Acad Dermatol Venereol 77
Br J Dermatol 57
J Am Acad Dermatol 57
Dermatol Pract Concept 54
Dermatology 44

Best Journals

J Clin Oncol 3
Ann Oncol 2
Nat Med 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Topical Dapsone for Recalcitrant Erosive Pustular Dermatosis of the Scalp in a Patient Unsuitable for Systemic Dapsone.
PMID 42865007 — skin diseases, dapsone, dermatology		Int J Dermatol20260
Concomitant oral and genital mucosal involvement in classical Sweet syndrome.
PMID 42687708 — oral ulcer, sweet syndrome		Dermatol Reports20260
Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study.
PMID 42670280 — sexually transmitted diseases, alopecia areata, skin diseases, adolescent, alopecia		J Eur Acad Dermatol Venereol20260
Predictors of outcomes and satisfaction with tirbanibulin in actinic keratosis: a multicenter real-world study.
PMID 42634952 — keratosis, keratosis, actinic, skin diseases, physicians, therapeutics		Ital J Dermatol Venerol20260
Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.
PMID 42605165 — quality of life, syphilis, vitiligo, therapeutics, dermatology, mental health		Br J Dermatol20261

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 1

By phase:

N/A 3
Phase 2 3
Phase 3 1

By status:

Recruiting 3
Completed 2
Active not recruiting 1
Unknown 1

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 4

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A phase II open label study improving compliance and time of treatment after obtaining complete response through a tailored schedule of sonidegib in locally advanced basal cell carcinomas (BCC) the SONIBEC trial
2024-516797-29-00 — cells, therapeutics, carcinoma, basal cell, carcinoma		Phase 2Active not recruiting2021
A phase II study of Sonidegib in Nevoid Basal Cell Carcinoma Syndrome (Gorlin) syndrome and sporadic BCC patients in EADO stage IIb SIBLINGS TRIAL
2024-515989-14-00 — cells, basal cell nevus syndrome, siblings, carcinoma, basal cell, carcinoma		Phase 2Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS